Cargando…

Corrigendum to ‘the anti-fecundity effect of 5-azacytidine (5-AzaC) on Schistosoma mansoni is linked to dis-regulated transcription, translation and stem cell activities’ [Int. J. Parasitol. Drugs and Drug Resist. 8 (2018) 213–222]

Detalles Bibliográficos
Autores principales:	Geyer, Kathrin K., Munshi, Sabrina E., Vickers, Martin, Squance, Michael, Wilkinson, Toby J., Berrar, Daniel, Chaparro, Cristian, Swain, Martin T., Hoffmann, Karl F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Regular article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288006/ https://www.ncbi.nlm.nih.gov/pubmed/30029996 http://dx.doi.org/10.1016/j.ijpddr.2018.07.002

Ejemplares similares

The anti-fecundity effect of 5-azacytidine (5-AzaC) on Schistosoma mansoni is linked to dis-regulated transcription, translation and stem cell activities
por: Geyer, Kathrin K., et al.
Publicado: (2018)

Corrigendum to “Rational approach to drug discovery for human schistosomiasis” [Int. J. Parasitol. Drugs Drug Resist. 16 (2021) 140–147]
por: LoVerde, Philip T., et al.
Publicado: (2022)

The Chromatin Assembly Factor Complex 1 (CAF1) and 5-Azacytidine (5-AzaC) Affect Cell Motility in Src-transformed Human Epithelial Cells
por: Endo, Akinori, et al.
Publicado: (2017)

Corrigendum to “Therapeutic effect of ursolic acid in experimental visceral leishmaniasis” [Int. J. Parasitol. Drugs Drug Resist. 7 (2017) 1–11]
por: Jesus, Jessica A., et al.
Publicado: (2017)

Erratum to “Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites” [Int. J. Parasitol. Drugs Drug Res. 5 (2015) 117–126]
por: Engel, Jessica A., et al.
Publicado: (2016)

Corrigendum to “Genetic diversity of next generation antimalarial targets: A baseline for drug resistance surveillance programmes” [Int. J. Parasitol. Drugs and Drug Resist. 7 (2017) 174–180]
por: Gomes, Ana Rita, et al.
Publicado: (2017)

Effects of 5-azaC on Iridoid Glycoside Accumulation and DNA Methylation in Rehmannia glutinosa
por: Dong, Tianyu, et al.
Publicado: (2022)

Transcriptome profiling of ‘Kyoho’ grape at different stages of berry development following 5-azaC treatment
por: Guo, Da-Long, et al.
Publicado: (2019)

Development of an Oral Form of Azacytidine: 2′3′5′Triacetyl-5-Azacytidine
por: Ziemba, Amy, et al.
Publicado: (2011)

Dear Editor-in-Chief Iranian J Parasitol
por: Gholami, SH
Publicado: (2012)

Effect of DNA methylation, modified by 5-azaC, on ecophysiological responses of a clonal plant to changing climate
por: Kosová, Veronika, et al.
Publicado: (2022)

Reply: Dear Editor-in-Chief Iranian J Parasitol
por: Fakhar, Mahdi
Publicado: (2012)

Clarification on a Published Paper in Iran J Parasitol
por: DEGERLI, Serpil, et al.
Publicado: (2015)

Hader (J Infect Dis 2016; 213[suppl 2]:S34)
Publicado: (2016)

Teriflunomide restores 5-azacytidine sensitivity via activation of pyrimidine salvage in 5-azacytidine-resistant leukemia cells
por: Imanishi, Satoshi, et al.
Publicado: (2017)

Wang et al (J Infect Dis 2016; 213:1380–7)
Publicado: (2016)

Epigenetic drug 5-azacytidine impairs proliferation of rat limb buds in an organotypic model-system in vitro
por: Mužić, Vedrana, et al.
Publicado: (2013)

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry
por: Diamantopoulos, Panagiotis, et al.
Publicado: (2019)

Effect of the Addition Frequency of 5-Azacytidine in Both Micro- and Macroscale Cultures
por: Kadekar, Sandeep, et al.
Publicado: (2020)

Corrigendum to “Exposure of vaccinated and naive cattle to natural challenge from buffalo-derived Theileria parva” [Int. J. Parasitol. Parasites Wildl. 4(2) (2015) 244–251]
por: Sitt, Tatjana, et al.
Publicado: (2017)

Cytogenetic effect of 5-azacytidine in patients with hematological malignancies
por: Tsuda, Jessica Romy, et al.
Publicado: (2011)

CNS Involvement in AML Patient Treated with 5-Azacytidine
por: Vasilatou, Diamantina, et al.
Publicado: (2014)

Suppressing nonsense—a surprising function for 5-azacytidine
por: Shao, Ada, et al.
Publicado: (2014)

Nuclear ground state spins of the francium isotopes $^{208-213,220-222}$Fr
por: Ekström, C, et al.
Publicado: (1978)

Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports
por: Rohon, Peter, et al.
Publicado: (2012)

Effects of 5-Azacytidine on Growth and Hypocrellin Production of Shiraia bambusicola
por: Ma, Yan Jun, et al.
Publicado: (2018)

Priming Leukemia with 5-Azacytidine Enhances CAR T Cell Therapy
por: Xu, Ning, et al.
Publicado: (2021)

5-Azacytidine Is Insufficient For Cardiogenesis In Human Adipose-Derived Stem Cells
por: Wan Safwani, Wan Kamarul Zaman, et al.
Publicado: (2012)

5-Azacytidine in Chronic Myelomonocytic Leukemia: Case Report and Review of Literature.
por: Greco, M., et al.
Publicado: (2011)

A Comparative Analysis of 5-Azacytidine- and Zebularine-Induced DNA Demethylation
por: Griffin, Patrick T., et al.
Publicado: (2016)

Synthesis and Antiproliferative Activities of 5-Azacytidine Analogues in Human Leukemia Cells
por: Guo, Gang, et al.
Publicado: (2008)

DNA methylation patterns of Brachypodium distachyon chromosomes and their alteration by 5-azacytidine treatment
por: Borowska, Natalia, et al.
Publicado: (2011)

5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion
por: Bhuvanagiri, Madhuri, et al.
Publicado: (2014)

How to Diagnose Early 5-Azacytidine-Induced Pneumonitis: A Case Report
por: Misra, Srimanta Chandra, et al.
Publicado: (2017)

The effects of the DNA Demethylating reagent, 5-azacytidine on SMCHD1 genomic localization
por: Massah, S., et al.
Publicado: (2020)

Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways
por: Minařík, Lubomír, et al.
Publicado: (2022)

NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes
por: Becker, Jonas P., et al.
Publicado: (2021)

5-Azacytidine-Mediated Modulation of the Immune Microenvironment in Murine Acute Myeloid Leukemia
por: Ebelt, Nancy D., et al.
Publicado: (2022)

Resistance of Leukemia Cells to 5-Azacytidine: Different Responses to the Same Induction Protocol
por: Šimoničová, Kristína, et al.
Publicado: (2023)

5-Azacytidine and 5-aza-2'-deoxycytidine behave as different antineoplastic agents in B16 melanoma.
por: Cortvrindt, R., et al.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_9fb80fc5897rblj5jq0djn6273